Exacerbation of SLE nephritis after cyclophosphamide withdrawal.
D000293:Adolescent; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome
D003520:Cyclophosphamide